DuVall AS, McNeer J, Cheung MC, Adrianzen-Herrera DA, Advani A, Aljurf M, Audino A, Benitez L, Deeter A, Dworkin E, Hiltbrand O, Isenalumhe L, Li L, Miller-Chism C, Mozessohn L, Ng AP, Pu JJ, Shafer D, Madueno FV, Viny A, Wadhwa A, Yang J, Zarnegar-Lumley S, Mai HJ, Kanaan G, Sereda Y, Saldanha IJ, Balk EM, Stock W, Wolfson JA. American Society of Hematology 2026 guidelines for frontline management of acute lymphoblastic leukemia in adolescents and young adults. Blood Advances. 2026;10(13):10.1182/bloodadvances.2021006469
Magtoto CM, Mieruszynski S, Dong H, Ng AP, Di Rago L, Kueh AJ, Brzozowski M, Grohmann C, Walker JR, Chua NK, Dagley LF, Ciulli A, Lessene G, Herold MJ, Heath JK, Silke J, Feltham R. The benchmarking and application of tag-degraders in vivo to validate therapeutic targets. Nature Communications. 2026;:10.1038/s41467-026-73681-1
Schenk P, Devine SM, Cobbold SA, Geoghegan ND, Kyran EL, Ang C-S, Alexandrovics JA, Calleja DJ, Multari DH, Vaibhav V, Lu BGC, Klemm TA, Dagley LF, Lowes KN, Williamson NA, Eichhorn PJA, Ng AP, Feltham R, Komander D. Global analysis of cancer cell responses to USP9X inhibition. The EMBO Journal. 2026;45(9):10.1038/s44318-026-00742-y
Ng AP, Nutt SL. Flicking the switch for B-cell development. Genes & Development. 2026;40(3-4):10.1101/gad.353397.125
Greenwood M, Gangatharan S, Osborn M, Ng AP, Fleming S, Fedele P, Trahair T, Casey J, Mapp S, Cheung C, Armytage T, Henderson M, Sutton R, Rehn J, Page E, Heatley S, Button P, Rowley L, Larsen SR, Presgrave P, Kwan J, Bennett S, Fong CY, Pozza LD, Yeung D, White D, Group TALAL. Blinatumomab in de novo AYA ALL—Results of the Australasian Leukaemia and Lymphoma Group ALL09 “SUBLIME” study. HemaSphere. 2026;10(1):10.1002/hem3.70291
Morel-Kopp M-C, Levade M, Beutler L, Chen Q, Othman J, Steffen P, McKay MJ, Molloy MP, Selvadurai MV, Liang HPH, Whittaker S, van der Wal DE, Gabrielli S, Hamilton JR, Chen VM, Ng AP, Ward CM, Stevenson WS. Growth factor independent 1B is a metabolic regulator that exerts pleiotropic effects on platelet function. Journal of Thrombosis and Haemostasis. 2025;23(10):10.1016/j.jtha.2025.06.021
Collett S, Earnest L, Edeling MA, Yap AHY, Montoya JC, Attard C, Di Rago L, Farley A, Ng AP, Monagle P, Torresi J. Adenovirus vectors can infect mouse megakaryocytes – implications for vaccine-induced thrombosis/thrombocytopenia. Research and Practice in Thrombosis and Haemostasis. 2025;9(4):10.1016/j.rpth.2025.102909
Iland HJ, Reynolds J, Boddy AV, Schultz HB, Khoo L, Fleming S, Lane SW, Weber N, Gasiorowski R, Armytage T, Harrup R, Watson A-M, Tan P, Filshie R, Kwok F, Stevenson W, Yuen S, Ng AP, Rowley L, Marlton P, Wei AH, Group ALAL. ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL. Blood Advances. 2025;9(6):10.1182/bloodadvances.2024015397
Nie J, Ng AP, Nutt SL. Post-translational control of B lineage commitment. Nature Immunology. 2024;25(12):10.1038/s41590-024-02019-0
Anderton H, Bandala-Sanchez E, Simpson DS, Rickard JA, Ng AP, Di Rago L, Hall C, Vince JE, Silke J, Liccardi G, Feltham R. Correction to: RIPK1 prevents TRADD-driven, but TNFR1 independent, apoptosis during development. Cell Death & Differentiation. 2024;31(12):10.1038/s41418-024-01401-7
